Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01731015 · ClinicalTrials.gov registry record · Phase 1
Imaging Lung Function Using Oxygen Enhanced MRI
A Phase 1 study, sponsored by Hal C Charles.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT01731015 is a Phase 1 study that has completed, run by Hal C Charles. The registered enrollment target is 15 participants.
The verdict
NCT01731015, a Phase 1 study, has completed, sponsored by Hal C Charles.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
The goal of this study is to perform a pilot study to evaluate the utilization of oxygen as an inhaled contrast agent to image the airway spaces in normal and diseased human lungs to allow an effect size estimate to power future studies.
Interventions
- DRUG Medical Grade Oxygen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2012-01 |
| Est. Completion | 2012-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01731015
The ClinicalTrials.gov registry entry for NCT01731015 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hal C Charles, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Medical Grade Oxygen is the first listed.
NCT01731015 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01731015 about?
NCT01731015 is a clinical study titled "Imaging Lung Function Using Oxygen Enhanced MRI". The goal of this study is to perform a pilot study to evaluate the utilization of oxygen as an inhaled contrast agent to image the airway spaces in normal and diseased human lungs to allow an effect size estimate to power future studies.
What is the current status of trial NCT01731015?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2012-01. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01731015?
The interventions under investigation include: Medical Grade Oxygen (DRUG).
Who is sponsoring clinical trial NCT01731015?
This trial is sponsored by Hal C Charles, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.